Clinical Trial Update: A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 HIV vaccine trial evaluating Ad35-GRIN/ENV in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ad35-GRIN/ENV HIV vaccine

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV, HIV Infections | Phase 1 | Status: COMPLETED